Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06623435 · ClinicalTrials.gov registry record
Real World and Genomic Data Based Asthma Insight Through Network Analysis
A clinical trial of Asthma, sponsored by Icahn School of Medicine at Mount Sinai.
- Active
- Registry status
- 1,073
- Enrollment target
- 5
- Study locations
NCT06623435: Active study of Asthma, sponsored by Icahn School of Medicine at Mount Sinai.
NCT06623435 is a study of Asthma that is active but no longer recruiting, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 1,073 participants, below the 1,560-participant average among 374 other Asthma trials with a reported enrollment target (31% lower). The trial reports 5 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06623435, a study of Asthma, is active but no longer recruiting, sponsored by Icahn School of Medicine at Mount Sinai.
- ACTIVE NOT RECRUITING
- Registry status
- 1,073 participants
- Enrollment target
- 5
- Study locations
Study Summary
A retrospective and prospective observational study of asthma designed to determine real-world and molecular description of asthma according to treatment and type 2 biology
Primary Outcome
Description of asthma disease subtypes according to type 2 and non-type 2 biology and control or lack of control along a range of asthma treatments.
Conditions Studied
Study Locations (5)
New York
- Mount Sinai Beth Israel - New York
- Mount Sinai West - New York
- Mount Sinai Morningside - New York
- Mount Sinai Hospital - New York
Colorado
- National Jewish Health - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,073 participants |
| Start Date | 2019-11-07 |
| Est. Completion | 2025-12-31 |
What the registry record for NCT06623435 still lists
NCT06623435 is an observational study that tracks outcomes without assigning an intervention. Its 1,073 participants enrollment target places it among the larger protocols in the corpus, below the 1,560-participant average among 374 other Asthma trials with a reported enrollment target (31% lower).
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 0 interventions.
NCT06623435 lists 5 locations in 2 states (New York, Colorado).
Frequently Asked Questions
What is clinical trial NCT06623435 about?
NCT06623435 is a clinical study titled "Real World and Genomic Data Based Asthma Insight Through Network Analysis". A retrospective and prospective observational study of asthma designed to determine real-world and molecular description of asthma according to treatment and type 2 biology
What is the current status of trial NCT06623435?
This trial is currently active not recruiting. The enrollment target is 1,073 participants. The study started on 2019-11-07. Estimated completion is 2025-12-31.
What conditions does trial NCT06623435 study?
This clinical trial studies the following conditions: Asthma.
Who is sponsoring clinical trial NCT06623435?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06623435 being conducted?
This trial has 5 study locations across Colorado, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06623435's enrollment target sits among peer trials
1,073 37th of 374 higher than 338 of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Innate Immunity in Allergic Asthma
RECRUITING
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Impact of Metabolic Dysfunction and Mucus Plugging on Asthma Physiology
RECRUITING
-
Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
RECRUITING · Phase 3
-
Escitalopram in Asthma Patients With Frequent Exacerbation
RECRUITING · Phase 2
-
Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06159673 · 1,074 participants · Phase 2
ACP-204 in Adults With Alzheimer's Disease Psychosis
- NCT06751043 · 1,072 participants · NA
Preoperative Fasting vs. Not Fasting in Critically Ill Patients
- NCT06658808 · 1,075 participants · NA
Efficacy-Implementation Study for PC CARES in Rural Alaska
- NCT07084883 · 1,076 participants
Pivotal Trial of an Automated AI-based System for Early Diagnosis and Prediction of Late Age-related Macular Degeneration
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI